|
CONCEPTIS TECHNOLOGIES AND VELOS ANNOUNCE STRATEGIC PARTNERSHIP TO PROVIDE END-TO-END INTERNET-BASED CLINICAL RESEARCH PRODUCTS AND SERVICES
San Francisco, CA - January 14, 2003 Conceptis Technologies, Inc., creators of theheart.org, and Velos, Inc. today announced a strategic partnership to jointly market Conceptis’ Clinical Trial Central™ service line and Velos eResearch.
Conceptis’ Clinical Trial Central™ is an internet-based product and service line that provides communication, information sharing, training, reference materials and other functionality to support clinical trials for its members. Velos eResearch is an internet-based product line that supports the administration, study execution, and study management needs of clinical research investigators and sponsors. The companies plan to collaborate in producing integrated product and service offering for clients and co-promote the product lines.
”The investigator activities that lead up to trial data submission, such as protocol design, budgeting, IRB approvals, patient recruitment, patient scheduling, and task management, account for the bulk of controllable elapsed time in clinical trials,” observes Greg Ogrodnick, President of Conceptis. “Solving these problems requires getting useful information technology into the hands of investigators, quickly and inexpensively. Velos eResearch is the best product we’ve seen for these purposes.”
“ The ability to efficiently and effectively reach, educate, and train investigators, and to assemble prominent investigator teams is of significant economic value to clinical trial sponsors,” notes John McIlwain, President and CEO of Velos. “Conceptis’ award-winning, web-based education and training products and specialty medical websites, such as www.theheart.org, provide exceptional advantages for clinical trials sponsors to more cost-effectively and expediently execute trial research. An integrated Conceptis’ Clinical Trial Center™ and Velos eResearch offering is of great value for both investigators and study sponsors. “
About Conceptis
Conceptis Technologies is an established medical media company with a five-year track record of revenue growth and a business approach of providing marketing services to the pharmaceutical industry. The Company’s revenues are derived from a number of sources including its award winning Medical Cybersession™, Clinical Trial Center™ websites, and other tools for pharmaceutical company marketing and sales. Conceptis’ websites, www.theheart.org and www.jointandbone.org, are both recognized leaders for attracting prominent physicians in the fields of cardiovascular medicine and rheumatology/ orthopedics respectively. Headquartered in Montreal, Conceptis employs over 80 people in Canada and the United States. Conceptis is a privately held company. For more information about Conceptis, please visit www.conceptis.com.
About Velos
Velos is a leading designer and developer of next-generation healthcare information systems. Founded in 1997, Velos develops, markets, and supports an integrated suite of clinical research, patient care, administrative, and financial products. Velos’ internet products and turnkey solutions address the information needs of healthcare providers, investigators, and clinical research sponsors in clinical research and medical specialties. Velos products are used by over 200 healthcare organizations in the North America, Europe, and Asia. Velos is privately held with headquarters in Silicon Valley. Information regarding Velos may be obtained by contacting Madalynne Chapman (510-580-2661) mchapman@velos.com, or by visiting www.velos.com.
This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Actual results may differ materially from those projected. These forward-looking statements represent Conceptis’ and Velos’ judgment as of the date of this release. The companies disclaim any intent or obligation to update these forward-looking statements.
|
